Testing of an Oligonucleotide therapeutics approach to address the underlying cause of myotonic dystrophy type 2 (DM2).

Biotechnology Computer Science Energy Engineering Environmental Sciences Information Science Life Sciences Mathematics Medical Sciences

Military Sciences Natural Sciences Physical Sciences Plant Sciences Science Space Sciences Technology Transportation